Question follow-through · 124057
Haemophilia: Health Services
To ask the Secretary of State for Health and Social Care, what steps have been taken to address funding shortfalls and inequities between haemophilia centres around the UK, identified by 2024-25 peer review of haemophilia care.
About this written question
A written question asks a government minister for information in writing. Parliament publishes the question and any answer.
- Answering body
- Department of Health and Social Care
- Tabled
- 26 Mar 2026
- Target answer date
- 13 Apr 2026
- Answer
- 16 Apr 2026 · 21 calendar days after tabling
Elapsed calendar days describe the record timeline, not whether Parliament considers an answer on time.
Votes on this topic
- Terminally Ill Adults (End of Life) Bill: Second Reading · 11 Sept 2026
- Health Bill: Report Stage: Amendment 1 · 8 Sept 2026
- Health Bill: Report Stage: New Clause 143 · 8 Sept 2026
These Commons divisions share a topic label. The question did not necessarily lead to a vote.
Recorded timeline
26 Mar 2026
Question tabled
To ask the Secretary of State for Health and Social Care, what steps have been taken to address funding shortfalls and inequities between haemophilia centres around the UK, identified by 2024-25 peer review of haemophilia care.
13 Apr 2026
Target answer date
Date supplied by the official written-questions record.
16 Apr 2026
Answer published
It is crucial we protect the safety of haemophilia care, and the Government is committed to implementing recommendation 9 of the 2024 Infected Blood Inquiry report.The Government is committed to improving the lives of those living with rare diseases, such...
Official data retrieved 28 Sept 2026.
Later records
Possible follow-up questions
Strong links require the same MP, department and exact heading. Other same-department questions are shown as unreviewed candidates, not as confirmed follow-ups. No debate link is asserted unless a stable source relationship exists.
No later same-department questions indexed.
This is an absence in covered public data, not evidence that no follow-up occurred elsewhere.